MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr | ₹1,137 Cr |
What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹2,413 Cr |
| Mar2024 | ₹2,152 Cr |
| Mar2023 | ₹1,813 Cr |
| Mar2022 | ₹920 Cr |
| Mar2021 | ₹1,137 Cr |
How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,413 Cr | 12.12 | |
| Mar2024 | ₹2,152 Cr | 18.70 | |
| Mar2023 | ₹1,813 Cr | 97.15 | |
| Mar2022 | ₹920 Cr | -19.12 | |
| Mar2021 | ₹1,137 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,551.0 Cr | 1.7% | 8.3% | 9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.7% |
8.3% |
9.4% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses